EP3463427 - METHODS AND COMPOSITIONS FOR THE TREATMENT OF SECRETORY DISORDERS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 17.05.2024 Database last updated on 24.08.2024 | |
Former | The application is deemed to be withdrawn Status updated on 26.03.2021 | ||
Former | Request for examination was made Status updated on 08.03.2019 | ||
Former | The international publication has been made Status updated on 02.12.2017 | Most recent event Tooltip | 29.07.2024 | New entry: Additional fee for renewal fee: payment of fee | 29.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Board of Regents, The University of Texas System 201 West 7th Street Austin, TX 78701 / US | [2019/15] | Inventor(s) | 01 /
MANGELSDORF, David, J. 201 West 7th Street Austin TX 78701 / US | 02 /
KLIEWER, Steven, A. 201 West 7th Street Austin TX 78701 / US | 03 /
COATE, Katie, C. 201 West 7th Street Austin TX 78701 / US | 04 /
HERNANDEZ, Genaro 201 West 7th Street Austin TX 78701 / US | [2019/15] | Representative(s) | Lee, Nicholas John Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [N/P] |
Former [2019/15] | Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB Beselerstraße 4 22607 Hamburg / DE | Application number, filing date | 17803516.8 | 24.05.2017 | [2019/15] | WO2017US34288 | Priority number, date | US201662341591P | 25.05.2016 Original published format: US 201662341591 P | [2019/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017205517 | Date: | 30.11.2017 | Language: | EN | [2017/48] | Type: | A1 Application with search report | No.: | EP3463427 | Date: | 10.04.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.11.2017 takes the place of the publication of the European patent application. | [2019/15] | Search report(s) | International search report - published on: | US | 30.11.2017 | (Supplementary) European search report - dispatched on: | EP | 11.02.2020 | Classification | IPC: | A61K38/18, C07K14/50, A61P1/18 | [2020/11] | CPC: |
A61K38/1825 (EP,IL,US);
A61K38/18 (IL);
A61K9/0019 (IL,US);
A61K9/0053 (IL,US);
A61P1/18 (EP,IL,US);
C07K14/50 (EP,IL,US)
|
Former IPC [2019/15] | A61K38/18, C07K14/50 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/15] | Title | German: | VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON SEKRETORISCHEN ERKRANKUNGEN | [2019/15] | English: | METHODS AND COMPOSITIONS FOR THE TREATMENT OF SECRETORY DISORDERS | [2019/15] | French: | MÉTHODES ET COMPOSITIONS POUR LE TRAITEMENT DE TROUBLES SÉCRÉTOIRES | [2019/15] | Entry into regional phase | 17.12.2018 | National basic fee paid | 17.12.2018 | Search fee paid | 17.12.2018 | Designation fee(s) paid | 17.12.2018 | Examination fee paid | Examination procedure | deleted | Deletion: Application deemed to be withdrawn, date of legal effect [2024/25] | deleted | Date on which the examining division has become responsible | 17.12.2018 | Examination requested [2023/51] | 03.09.2020 | Amendment by applicant (claims and/or description) | 01.12.2020 | Application deemed to be withdrawn, date of legal effect [2021/17] | 22.12.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2024/25] | 24.10.2023 | Date of oral proceedings | 10.11.2023 | Minutes of oral proceedings despatched | 05.12.2023 | Despatch of a communication from the examining division (Time limit: M04) | 05.04.2024 | Reply to a communication from the examining division | Request for re-establishment of rights: | 26.03.2021 | Date of receipt | Fees paid | Renewal fee | 27.11.2019 | Renewal fee patent year 03 | 26.03.2021 | Renewal fee patent year 04 | 09.11.2023 | Renewal fee patent year 05 | 09.11.2023 | Renewal fee patent year 06 | 09.11.2023 | Renewal fee patent year 07 | 29.07.2024 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.05.2019 | 03   M06   Fee paid on   27.11.2019 | 31.05.2020 | 04   M06   Fee paid on   26.03.2021 | 31.05.2024 | 08   M06   Fee paid on   29.07.2024 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO03011213 (LILLY CO ELI [US], et al) [X] 1,6-15 * abstract * * page 3, line 21 - line 27 *; | [X]WO2011154349 (NOVO NORDISK AS [DK], et al) [X] 1,6-15 * abstract * * page 1, line 4 - line 8 *; | [X]WO2012066075 (NOVARTIS AG [CH], et al) [X] 1,6-15 * abstract * * paragraphs [0001] , [0010] , [0068] , [0069] , [0225] *; | [X]US2012172298 (ANDERSEN BIRGITTE [DK], et al) [X] 1,6-15 * abstract * * paragraphs [0006] , [0251] *; | [X] - Y. C. WOO ET AL, "Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives", CLINICAL ENDOCRINOLOGY, (20130312), vol. 78, no. 4, doi:10.1111/cen.12095, ISSN 0300-0664, pages 489 - 496, XP055125055 [X] 1,6-15 * abstract * DOI: http://dx.doi.org/10.1111/cen.12095 | [I] - JOHNSON C L ET AL, "Fibroblast Growth Factor 21 Reduces the Severity of Cerulein-Induced Pancreatitis in Mice", GASTROENTEROLOGY : OFFICIAL PUBLICATION OF THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION, WILLIAMS & WILKINS, US, vol. 137, no. 5, doi:10.1053/J.GASTRO.2009.07.064, ISSN 0016-5085, (20091101), pages 1795 - 1804, (20090805), XP026701655 [I] 1-15 * Conclusions * DOI: http://dx.doi.org/10.1053/j.gastro.2009.07.064 | [XP] - COATE KATIE C ET AL, "FGF21 Is an Exocrine Pancreas Secretagogue", CELL METABOLISM, CELL PRESS, UNITED STATES, (20170112), vol. 25, no. 2, doi:10.1016/J.CMET.2016.12.004, ISSN 1550-4131, pages 472 - 480, XP029914127 [XP] 1-15 * abstract * DOI: http://dx.doi.org/10.1016/j.cmet.2016.12.004 | International search | [A]US2013079500 (BOETTCHER BRIAN R [US], et al) [A] 1-20 * entire document *; | [A]US2013129724 (BOETTCHER BRIAN R [US], et al) [A] 1-20* entire document *; | [A]US2015284442 (LING LEI [US], et al) [A] 1 -20 * entire document *; | [X]WO2015195509 (NGM BIOPHARMACEUTICALS INC [US]) [X] 1, 6-8 * entire document *; | [X]WO2016065106 (NGM BIOPHARMACEUTICALS INC [US]) [X] 1-5, 9-20 * entire document *; | [A]WO2016065326 (BRISTOL MYERS SQUIBB CO [US]) [A] 1-20 * entire document * |